We report the development of a potent, selective histone deacetylase 6 (HDAC6) inhibitor. This HDAC6 inhibitor blocks growth of normal and transformed cells but does not induce death of normal cells. The HDAC6 inhibitor alone is as effective as paclitaxel in anticancer activity in tumor-bearing mice.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593111 | PMC |
| http://dx.doi.org/10.1073/pnas.1515882112 | DOI Listing |
Publication Analysis
Top Keywords
hdac6 inhibitor
12
histone deacetylase
8
creation histone
4
inhibitor
4
deacetylase inhibitor
4
inhibitor biological
4
biological effects
4
effects [corrected]
4
[corrected] report
4
report development
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!